Literature DB >> 27473655

In vitro selection of bispecific diabody fragments using covalent bicistronic DNA display.

Masanao Nakayama1, Shoko Komiya1, Kei Fujiwara1, Kenichi Horisawa1, Nobuhide Doi2.   

Abstract

Bispecific antibodies with two different antigen-binding sites have been widely used for a variety of medical applications. The activity and stability of antibody fragments can be improved by in vitro evolution. Although the affinity and stability of small bispecific antibody fragments such as diabodies can be further optimized by in vitro display technologies, cell-free display of bispecific antibody fragments has not been reported. In this study, we applied a covalent bicistronic DNA display for the in vitro selection of heterodimeric diabodies. First, we confirmed the antigen-binding activities of a diabody synthesized by an in vitro transcription and translation system. However, when we performed DNA-display selection of a model diabody library in a proof-of-principle experiment, no enrichment of the diabody gene was observed, likely due to a low yield of the diabody heterodimer. To overcome this issue, we introduced cysteine residues at the VH-VL interface of the diabody heterodimer. Using the disulfide-stabilized diabodies, we successfully enriched the diabody gene from a model library. Our results indicate that the covalent bicistronic DNA display technique could be useful for improving the stability and affinity of bispecific diabody fragments.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bispecific antibody; Cell-free protein synthesis; Display technology; Disulfide stabilization; PURE system

Mesh:

Substances:

Year:  2016        PMID: 27473655     DOI: 10.1016/j.bbrc.2016.07.113

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  1 in total

1.  Cell-free synthesis of functional antibodies using a coupled in vitro transcription-translation system based on CHO cell lysates.

Authors:  M Stech; O Nikolaeva; L Thoring; W F M Stöcklein; D A Wüstenhagen; M Hust; S Dübel; S Kubick
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.